Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
Translation01:31

Translation

141.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.8K
Mutations01:39

Mutations

81.6K
Overview
81.6K
Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

7.6K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.6K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.6K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the attitudinal and behavioral consequences of work-life balance considering the mediating role of psychological contract violation among english language teachers.

BMC psychology·2025
Same author

Entinostat and novel analogs: preclinical evidence for anti-proliferative activity in adult T-cell leukemia/lymphoma.

Medical oncology (Northwood, London, England)·2025
Same author

Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs.

Journal of chemotherapy (Florence, Italy)·2024
Same author

Umbelliprenin improved anti-proliferative effects of ionizing radiation on adult T-cell leukemia/lymphoma cells via interaction with CDK6; an <i>in vitro</i> and <i>in silico</i> study.

International journal of immunopathology and pharmacology·2024
Same author

Comparing toxicity of galbanic acid, auraptene and umbelliprenin on adult T-cell leukaemia-lymphoma in normoxia and hypoxia.

Cellular and molecular biology (Noisy-le-Grand, France)·2023
Same author

Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin.

Dose-response : a publication of International Hormesis Society·2022

Related Experiment Video

Updated: Jun 21, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K

DNMT3A-R882: a mutation with many paradoxes.

Pourya Arbab Jafari1, Ramin Bagheri2, Soroush Lavasani3

  • 1Deakin University, Melbourne, Australia.

Annals of Hematology
|July 5, 2024
PubMed
Summary

The R882 mutation in DNA methyltransferase 3A (DNMT3A) is a key factor in acute myeloid leukemia (AML) progression, impacting stem cell differentiation and treatment response.

Keywords:
AMLDNMT3APrognosisR882 mutation

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.7K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

Related Experiment Videos

Last Updated: Jun 21, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.7K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) pathogenesis involves complex genetic and epigenetic alterations.
  • DNA (cytosine-5)-methyltransferase 3A (DNMT3A) is a critical epigenetic regulator in hematopoiesis.
  • The R882 hotspot mutation in DNMT3A is frequently observed in AML patients.

Purpose of the Study:

  • To elucidate the prognostic and therapeutic significance of the DNMT3A R882 mutation in AML.
  • To analyze the impact of this mutation on hematopoietic stem cell differentiation and disease progression.
  • To review the variable prevalence and prognostic implications across diverse populations.

Main Methods:

  • Literature review and meta-analysis of studies investigating DNMT3A R882 mutations in AML.
  • Analysis of mutation prevalence, clinical characteristics, and treatment outcomes.
  • Examination of the association between R882 mutations and co-occurring mutations (e.g., NPM1, FLT3).

Main Results:

  • The DNMT3A R882 mutation is linked to impaired hematopoietic stem cell differentiation and AML progression.
  • Prevalence and prognostic impact of the R882 mutation vary significantly across ethnic groups and geographical regions.
  • Co-occurrence with NPM1 and FLT3 mutations is frequent and associated with a poorer prognosis.
  • Treatment response, particularly to bone marrow transplantation, shows heterogeneous outcomes, with chemoresistance being a common finding.

Conclusions:

  • The DNMT3A R882 mutation is a significant factor influencing AML prognosis and treatment strategies.
  • Further research is needed to understand the precise mechanisms and clinical implications of this mutation.
  • Personalized treatment approaches considering the R882 mutation status may improve patient outcomes in AML.